↓ Skip to main content

Clinical outcomes for patients after surgery and radiation therapy for mesenchymal chondrosarcomas

Overview of attention for article published in Seminars in Surgical Oncology, October 2016
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
20 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Clinical outcomes for patients after surgery and radiation therapy for mesenchymal chondrosarcomas
Published in
Seminars in Surgical Oncology, October 2016
DOI 10.1002/jso.24435
Pubmed ID
Authors

Karen De Amorim Bernstein, Norbert Liebsch, Yen‐Lin Chen, Andrzej Niemierko, Joseph H. Schwab, Kevin Raskin, Santiago A. Lozano‐Calderon, Gregory Cote, David C. Harmon, Edwin Choy, Alex Haynes, John Mullen, Francis J. Hornicek, Thomas F. DeLaney

Abstract

We report the outcome of 23 patients with mesenchymal chondrosarcomas treated with surgery and radiation therapy +/- chemotherapy. The intent of the project was to review the impact of patient and treatment variables on treatment outcome, in particular with regard to extent of surgery and radiation dose. Twenty-three patients with mesenchymal chondrosarcomas were treated with surgery and radiation therapy (min. dose 44 Gy; max. dose 78 Gy; median dose 60 Gy; mean dose 61 Gy). The median survival for the entire cohort of patients was 21.65 years (95% confidence interval ± 4.25). The 5- and 10-year OS was 78.6%. Median disease-free survival for the 23 patients was 7.2 years. Disease-free survival (DFS) at 3 and 5 years was 70.7% and 57.8%, respectively. The local control rate at 5 and 10 years was 89.5% (95%CI 64.1-97.3%). Only three patients experienced local failure, three patients had regional failure, and eight developed distant metastases. In this cohort of patients local tumor control was high when using a combination of surgery and radiation. There was not a clear relationship between radiation dose and local tumor control. J. Surg. Oncol. © 2016 Wiley Periodicals, Inc.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 20 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 20 100%

Demographic breakdown

Readers by professional status Count As %
Student > Postgraduate 3 15%
Researcher 2 10%
Professor > Associate Professor 2 10%
Student > Master 2 10%
Student > Doctoral Student 1 5%
Other 2 10%
Unknown 8 40%
Readers by discipline Count As %
Medicine and Dentistry 10 50%
Neuroscience 1 5%
Unknown 9 45%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 October 2016.
All research outputs
#22,759,802
of 25,374,917 outputs
Outputs from Seminars in Surgical Oncology
#2,196
of 2,799 outputs
Outputs of similar age
#280,420
of 320,684 outputs
Outputs of similar age from Seminars in Surgical Oncology
#28
of 43 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,799 research outputs from this source. They receive a mean Attention Score of 3.6. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 320,684 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 43 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.